Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Health-related quality of life measurements with linvoseltamab treatment for relapsed/refractory myeloma in LINKER-MM1 show improvements in pain, fatigue, and functioning among triple-class-exposed RRRMM.”
Title: Health-related quality of life with linvoseltamab treatment for relapsed/refractory multiple myeloma in LINKER-MM1
Authors: James E. Hoffman, Naresh Bumma, Joshua Richter, Madhav V. Dhodapkar, Hans C. Lee, Attaya Suvannasankha, Jeffrey A. Zonder, Joseph J. Maly, Mansi R. Shah, Rachid Baz, Timothy J. Inocencio, Michelle DeVeaux, Cristina Ivanescu, Karen Rodriguez Lorenc, Glenn S. Kroog, Katherine Knorr, Lei Chi, James Harnett, Qiufei Ma, Sundar Jagannath
You can read the full article on Blood Neoplasia.

You can find other articles featuring Robert Orlowski on OncoDaily.